Study Group: Rheumatologists (EU)(?)
Council Members in this Study Group: 209
Request a survey with this Study Group
Related Study Groups
| Study Group Name | Members |
|---|---|
| Rheumatologists | 859 |
| Physicians (Germany) | 1146 |
| Gouty Arthritis Specialists (EU) | 27 |
| Rheumatoid Arthritis Specialists (EU) | 13 |
| Orthopedic Surgeons (EU) | 353 |
| Pediatricians (EU) | 331 |
| Rituxan Prescribers: Rheumatologists | 35 |
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
This article is of interest since it deals with the problems plaguing major drug manufacturers, which in essence can be seen as a consequence of declining job satisfaction and creativity among the investigators. The fundsamental reason behinf the´difficulty ...
- the next generation of SMIP technology beyond antibody therapy enters clinical trials - the value of efficacy versus safety as compared to TRU-015 and the anti-CD20 antiobodies will be of key importance if it makes sense to broaden this spectrum of second generation anti-CD20s - however, it gives...
Heavy marketing has saturated potential target patients Tolerance problems limit the use Competitors, sitaxentan and ambrisentan arriving and will steal market shares
Most Common Company Types:
- Academic Medical Center/Hospital or Clinic
- Government/Military Hospital or Clinic
- Academic Institution*
- Office Based Private Practice or Clinic
- Non-Academic Community Hospital or Clinic
Most Common Job Types:
- Physician - Attending Physician
- Physician - Division Head
- Professor
- Physician - Director
- Physician - Department Chair
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms